Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Herold

Showing results (31-40 of 804) with videos related to

Pageof 81
Sort By:
Current Diabetes Reports|July 22, 2004
Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulationMariela Glandt, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|December 21, 2006
Islet transplantation for type 1 diabetes--where should we go?Piotr Witkowski, Kevan C Herold
Diabetes/Metabolism Research and Reviews|March 26, 2009
Anti-CD3 mAbs for treatment of type 1 diabetesAdam Kaufman, Kevan C Herold
Cold Spring Harbor Perspectives in Medicine|June 8, 2012
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetesJasmin Lebastchi, Kevan C Herold
Der Radiologe|November 9, 2017
[Posttreatment alterations to the musculoskeletal system]C Schueller-Weidekamm, C Herold
Archives of Oral Biology|August 1, 1970
The development and mature structure of dentine in the Pike, Esox lucius, analyzed by bright field, phase and polarization microscopyR C Herold, L Landino
The Journal of General Virology|August 20, 2002
Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spreadNatalia Cheshenko, Betsy C Herold
HNO|February 24, 2005
[Antitumour vaccination in patients with ENT tumours. Successful track record]G Dyckhoff, C Herold-Mende
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: New immunomodulatory therapies in type 1 diabetesSimona Cernea, Kevan C Herold
Immunologic Research|November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?Kevan C Herold, Lesley Taylor
Pageof 81

Showing results (31-40 of 804) with videos related to

Sort By:
Pageof 81
Current Diabetes Reports|July 22, 2004
Treatment of type 1 diabetes with anti-T-cell agents: from T-cell depletion to T-cell regulationMariela Glandt, Kevan C Herold
Nature Clinical Practice. Endocrinology & Metabolism|December 21, 2006
Islet transplantation for type 1 diabetes--where should we go?Piotr Witkowski, Kevan C Herold
Diabetes/Metabolism Research and Reviews|March 26, 2009
Anti-CD3 mAbs for treatment of type 1 diabetesAdam Kaufman, Kevan C Herold
Cold Spring Harbor Perspectives in Medicine|June 8, 2012
Immunologic and metabolic biomarkers of β-cell destruction in the diagnosis of type 1 diabetesJasmin Lebastchi, Kevan C Herold
Der Radiologe|November 9, 2017
[Posttreatment alterations to the musculoskeletal system]C Schueller-Weidekamm, C Herold
Archives of Oral Biology|August 1, 1970
The development and mature structure of dentine in the Pike, Esox lucius, analyzed by bright field, phase and polarization microscopyR C Herold, L Landino
The Journal of General Virology|August 20, 2002
Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spreadNatalia Cheshenko, Betsy C Herold
HNO|February 24, 2005
[Antitumour vaccination in patients with ENT tumours. Successful track record]G Dyckhoff, C Herold-Mende
Nature Clinical Practice. Endocrinology & Metabolism|August 26, 2006
Drug insight: New immunomodulatory therapies in type 1 diabetesSimona Cernea, Kevan C Herold
Immunologic Research|November 12, 2003
Treatment of Type 1 diabetes with anti-CD3 monoclonal antibody: induction of immune regulation?Kevan C Herold, Lesley Taylor
Pageof 81